Clinical Liver Disease

Drug resistance: Prevalence and clinical implications during the treatment of chronic hepatitis C infection, Jean-Michel Pawlotsky - Article Reading

Informações:

Synopsis

The recent development of direct-acting antiviral (DAA) molecules that are active on hepatitis C virus (HCV) has raised the concern that resistance may undermine therapy based on DAAs.